Tilray Inc (NASDAQ:TLRY - Get Free Report)'s share price was down 7.7% during mid-day trading on Thursday . The stock traded as low as $0.43 and last traded at $0.44. Approximately 18,260,827 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 29,344,328 shares. The stock had previously closed at $0.48.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on TLRY shares. Piper Sandler cut their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. Canaccord Genuity Group lifted their price objective on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a report on Monday, January 13th. Finally, Roth Capital reaffirmed a "neutral" rating on shares of Tilray in a report on Monday, April 14th.
Read Our Latest Analysis on Tilray
Tilray Price Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The company has a market capitalization of $419.69 million, a P/E ratio of -1.49 and a beta of 1.88. The firm's 50-day moving average is $0.67 and its 200-day moving average is $1.12.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $185.78 million for the quarter, compared to analysts' expectations of $213.38 million. Analysts predict that Tilray Inc will post -0.2 EPS for the current fiscal year.
Institutional Trading of Tilray
Several institutional investors and hedge funds have recently modified their holdings of the company. Lido Advisors LLC bought a new stake in Tilray during the fourth quarter valued at about $28,000. Dudley Capital Management LLC bought a new stake in Tilray during the 4th quarter valued at approximately $29,000. Verdence Capital Advisors LLC purchased a new position in Tilray in the 4th quarter worth approximately $29,000. Ameritas Advisory Services LLC bought a new position in Tilray in the 4th quarter worth approximately $32,000. Finally, Newman Dignan & Sheerar Inc. grew its position in shares of Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
